145 related articles for article (PubMed ID: 25073514)
1. NBS1 Glu185Gln polymorphism and susceptibility to urinary system cancer: a meta-analysis.
Zhang Y; Huang YS; Lin WQ; Zhang SD; Li QW; Hu YZ; Zheng RL; Tang T; Li XZ; Zheng XH
Tumour Biol; 2014 Nov; 35(11):10723-9. PubMed ID: 25073514
[TBL] [Abstract][Full Text] [Related]
2. Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: a meta-analysis.
Yao F; Fang Y; Chen B; Jin F; Wang S
Tumour Biol; 2013 Apr; 34(2):1255-62. PubMed ID: 23381647
[TBL] [Abstract][Full Text] [Related]
3. Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis.
Wang L; Cheng J; Gao J; Wang J; Liu X; Xiong L
Mol Biol Rep; 2013 Mar; 40(3):2711-5. PubMed ID: 23275190
[TBL] [Abstract][Full Text] [Related]
4. NBS1 Glu185Gln polymorphism and cancer risk: update on current evidence.
He YZ; Chi XS; Zhang YC; Deng XB; Wang JR; Lv WY; Zhou YH; Wang ZQ
Tumour Biol; 2014 Jan; 35(1):675-87. PubMed ID: 23979977
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Double-strand Break Repair Gene Nijmegen Breakage Syndrome 1 Genotypes, Gender Difference and Smoking Status to Taiwanese Lung Cancer.
Chuang CL; Wang CH; Hsu CH; Hsiao CL; Chen GL; Yen ST; Li HT; Chang WS; Tsai CW; Wang SC; Bau DT
Anticancer Res; 2017 May; 37(5):2417-2423. PubMed ID: 28476809
[TBL] [Abstract][Full Text] [Related]
6. The functional polymorphism of NBS1 p.Glu185Gln is associated with an increased risk of lung cancer in Chinese populations: case-control and a meta-analysis.
Fang W; Qiu F; Zhang L; Deng J; Zhang H; Yang L; Zhou Y; Lu J
Mutat Res; 2014 Dec; 770():61-8. PubMed ID: 25771871
[TBL] [Abstract][Full Text] [Related]
7. Association of Nijmegen Breakage Syndrome 1 Genotypes With Bladder Cancer Risk.
Chen M; Chang WS; Shen TC; Gong CL; Lin ML; Wang ZH; Wang YC; Chen CH; Wu HC; Bau DT; Tsai CW
Anticancer Res; 2020 Apr; 40(4):2011-2017. PubMed ID: 32234891
[TBL] [Abstract][Full Text] [Related]
8. Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis.
Lu M; Lu J; Yang X; Yang M; Tan H; Yun B; Shi L
BMC Cancer; 2009 Apr; 9():124. PubMed ID: 19393077
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.
Huang MD; Chen XF; Xu G; Wu QQ; Zhang JH; Chen GF; Cai Y; Qi FZ
DNA Cell Biol; 2012 May; 31(5):678-82. PubMed ID: 22070649
[TBL] [Abstract][Full Text] [Related]
11. Effect of NBS1 gene polymorphism on the risk of cervix carcinoma in a northern Indian population.
Sobti RC; Shekari M; Kordi Tamandani DM; Kaur P; Suri V; Huria A
Int J Biol Markers; 2008; 23(3):133-9. PubMed ID: 18949738
[TBL] [Abstract][Full Text] [Related]
12. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
[TBL] [Abstract][Full Text] [Related]
13. Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.
Zhang G; Zeng Y; Liu Z; Wei W
Tumour Biol; 2013 Oct; 34(5):2753-7. PubMed ID: 23765759
[TBL] [Abstract][Full Text] [Related]
14. Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
Zeng Y; Jiang HY; Wei L; Xu WD; Wang YJ; Wang YD; Liu C
Asian Pac J Cancer Prev; 2015; 16(16):7249-54. PubMed ID: 26514519
[TBL] [Abstract][Full Text] [Related]
15. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
Wang Z; Cui D; Lu W
Breast Cancer Res Treat; 2010 Sep; 123(2):557-61. PubMed ID: 20143155
[TBL] [Abstract][Full Text] [Related]
16. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
17. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
[TBL] [Abstract][Full Text] [Related]
18. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
19. The association between the Lys751Gln polymorphism in the XPD gene and the risk of bladder cancer.
Xiong T; Yang J; Wang H; Wu F; Liu Y; Xu R; Lv Z; Xue P; Cao W; Zhang Y
Mol Biol Rep; 2014; 41(4):2629-34. PubMed ID: 24535265
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
Dong LM; Zhang XY; Teng H; Li MS; Wang P
Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
